Abstract

BackgroundPrevious studies have indicated that chitinase 3-like 1 (CHI3L1) gene rs4950928 polymorphism and acidic mammalian chitinase (AMCase or CHIA) gene rs10494132 polymorphism are associated with the risk of asthma. However, the results are inconsistent because of small sample size and varied ethnicity and age in studies. Therefore, a systematic meta-analysis was important to clarify the effect of CHI3L1 rs4950928 polymorphism and CHIA rs10494132 variant on asthma risk.MethodsAn electronic literature search was conducted to identify all the eligible studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated and sensitivity analysis as well as publication bias were assessed to investigate the associations. All statistical analyses were performed using STATA 12.0.ResultsEight published articles with 10 case-control studies were included, 5 studies were of CHI3L1 rs4950928 polymorphism and another 5 studies involved CHIA rs10494132 polymorphism. Overall, no significant association was found between CHI3L1 polymorphism and asthma susceptibility. After stratified according to ethnicity, CHI3L1 rs4950928 variant was associated with decreased asthma risk in Caucasians (GG + GC vs. CC: OR = 0.621, 95% CI = 0.484–0.797, P = 0.000; GC vs. CC: OR = 0.612, 95% CI = 0.470–0.796, P = 0.000; G vs. C: OR = 0.696, 95% CI = 0.567–0.856, P = 0.001). When stratified population by age, there was no association in children under all genetic models. As for CHIA rs10494132 polymorphism, no evidence of association between CHIA rs10494132 polymorphism and asthma risk was identified. Furthermore, subgroup analysis by ethnicity revealed a positive correlation between CHIA rs10494132 polymorphism and asthma risk among Asians (TT vs. TC + CC: OR = 1.476, 95% CI = 1.071–2.032, P = 0.017; T vs. C: OR = 1.326, 95% CI = 1.024–1.717, P = 0.032). Additionally, in the subgroup analysis conducted according to age, CHIA rs10494132 variant was also found to be associated with the increased risk of asthma in children (TT vs. TC + CC: OR = 1.472, 95% CI = 1.067–2.030, P = 0.019; T vs. C: OR = 1.320, 95% CI = 1.016–1.713, P = 0.037).ConclusionsThe G allele of CHI3L1 rs4950928 might be a protective factor against the development of asthma. However, the rs10494132 polymorphism of CHIA might be a risk factor for asthma.

Highlights

  • Previous studies have indicated that chitinase 3-like 1 (CHI3L1) gene rs4950928 polymorphism and acidic mammalian chitinase (AMCase or Acidic mammalian chitinase (CHIA)) gene rs10494132 polymorphism are associated with the risk of asthma

  • After a systematical literature search based on the inclusion criteria, 10 case-control studies from 8 published articles containing 1858 cases and 1778 controls were identified for this meta-analysis to investigate the relations of CHI3L1 and CHIA variants with asthma risk [7, 8, 18, 20,21,22,23,24]

  • In the subgroup analysis conducted according to age, CHIA rs10494132 variant was found to be associated with the increased risk of asthma in children under the recessive model (TT vs. TC + CC: Odds ratio (OR) = 1.472, 95% Confidence interval (CI) = 1.067–2.030, P = 0.019) and the allele model (T vs. C: OR = 1.320, 95% CI = 1.016–1.713, P = 0.037) (Fig. 4)

Read more

Summary

Introduction

Previous studies have indicated that chitinase 3-like 1 (CHI3L1) gene rs4950928 polymorphism and acidic mammalian chitinase (AMCase or CHIA) gene rs10494132 polymorphism are associated with the risk of asthma. With numerous advances in genetic research, many genetic variants regulating the expression of proteins involved in the development of asthma have been found to be related to susceptibility to this disease, including interleukin-17F (IL-17F), toll-like receptor 4 (TLR4), and the genes encoding chitinase 3–like 1 (CHI3L1) and acidic mammalian chitinase (AMCase or CHIA) [5,6,7,8]. Recent genetic study has described that several CHIA polymorphisms is related to asthma risk in a German pediatric population [19]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call